A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.

Details

Language :

English

ISSN :

03406245

Volume :

113

Issue :

5

Database :

Complementary Index

Journal :

Thrombosis & Haemostasis

Publication Type :

Academic Journal

Accession number :

109336603

Full Text :

https://doi.org/10.1160/TH14-12-1080